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Abstract
Thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361 isolated from
honey, strongly inhibited the growth of Bacillus cereus F4552. The bacteriocin was
purified by 65% ammonium sulfate precipitation of the culture supernatant,
followed by octyl-sepharose CL-4B and reverse-phase HPLC. The molecular mass
of the bacteriocin was determined to be 3139.51Da and the 14 amino acids of the
bacteriocin at the N-terminus were identified. The complete amino acid sequence
of mature thurincin H was deduced from three structural genes, thnA1, thnA2, and
thnA3 found in tandem repeats on the chromosome, all of which encode for the
same bacteriocin, thurincin H. The genetic determinants for thurincin H
biosynthesis consist of 10 ORFs, including three thurincin H structural genes.
Northern hybridization elucidated that the transcription of all three bacteriocin
structural genes was regulated by a putative promoter located upstream of thnA1.
Introduction
Bacteriocins are relatively small (3–10 kDa), cationic anti-
bacterial peptides produced by Gram-positive and -negative
bacteria (Klaenhammer, 1993). They can exert their antag-
onistic activity by disrupting membrane ionic potential
through pore formation on the target cell membrane
(He´chard & Sahl, 2002). Bacteriocins have been studied as
potential alternatives to food preservatives that include
sodium benzoate, potassium sorbate and sulfur dioxide that
are currently used in the food industry (Ross et al., 2002).
Bacteriocins from food-grade microorganisms such as lactic
acid bacteria are generally regarded as safe due to historical
use in foods and the sensitivity of the bacteriocins to
intestinal proteolytic enzymes when applied in the food,
livestock and agricultural industry. Nisin is a bacteriocin
produced by Lactococcus lactis ssp. lactis that has been
applied to processed cheeses and other dairy products for
4 40 years in 4 50 countries of the world (Ross et al., 2002;
Delves-Broughton, 2005).
The Bacillus genus has been known to produce various
types of bacteriocins (Stein, 2005). Subtilin, produced by
Bacillus subtilis, is a lantibiotic, containing post-translation-
ally modified unusual amino acids, such as lanthionine and
methyllanthionine, and contain disulfide linkages between
cysteine residues in the structure. The genes associated with
subtilin production, immunity, modification, transport and
regulatory system have been well investigated (Kleerebezem,
2004). Another lantibiotic, subtilosin A, produced by B.
subtilis has been well studied and the genetic determinants
for production and immunity (sbo-alb) have been identified
(Babasaki et al., 1985; Zheng et al., 1999). Bacillus cereus is
phylogenetically very similar to Bacillus thuringiensis and
produces several bacteriocins exerting antibacterial activity
against closely related Bacillus species (Naclerio et al., 1993;
Osca´riz et al., 1999, 2006; Sebei et al., 2007). Moreover, B.
thuringiensis strains have been reported to produce a variety
of bacteriocins (Paik et al., 1997; Cherif et al., 2001, 2003;
Ahern et al., 2003; Kamoun et al., 2005; Gray et al., 2006b;
Chehimi et al., 2007) that show high levels of antibacterial
activity against closely related Bacillus species.
Previously, we isolated bacteria from different varieties of
honey to determine the incidence of antimicrobial produc-
tion and it was observed that as many as 92.5% of bacteria
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from specific honey varieties produced antimicrobial com-
pounds (Lee et al., 2008a). In this study, a bacterial strain, B.
thuringiensis SF361, isolated from sunflower honey was
selected to characterize the nature of the antimicrobial
activity exhibited by the producer strain, which showed a
high level of antagonistic activity against Gram-positive
food-borne pathogens. To understand the primary structure
and the genetic determinants of the bacteriocin, the struc-
tural and accessory genes were cloned and transcriptional
analysis was performed to elucidate how the structural genes
are transcribed.
Materials and methods
Screening and identification of the producer
strain
An isolate (no. 361) from sunflower honey (South Dakota),
screened by Lee et al. (2008a), displaying a high level of
antibacterial activity against B. cereus F4552, was selected for
further characterization of the antibacterial compound.
Gram staining and 16S rRNA gene sequencing by PCR with
set 1 primers (Table 1) was conducted to identify the
producer strain as described by Lee et al. (2009a). To amplify
gyrB gene as described by Manzano et al. (2003), set 2
primers (Table 1) were designed to perform PCR under the
following conditions; one cycle of 3min at 94 1C, followed
by 30 cycles of 30 s denaturation at 94 1C, 30 s annealing at
57 1C, and 30 s extension at 72 1C and the last cycle of 8min
at 72 1C.
The PCR products were eluted using Qiagen Gel extrac-
tion kit (Qiagen, Valencia, CA) and the eluted products were
sequenced by the Cornell University Life Science Core
Laboratories Center (Ithaca, NY). The sequencing results
were analyzed using NCBI BLAST homology search (BLASTN)
to identify the producer strain.
Antibacterial spectrum of bacteriocin producer
Bacillus thuringiensis SF361 was replica plated on tryptic soy
agar (BD, Sparks, MD) plates and incubated at 30 1C for
24 h. The antibacterial spectrum of B. thuringiensis SF361
was determined against 41 indicator strains including food
spoilage and pathogenic bacteria (Table 2) by deferred
inhibition assay as described by Lee et al. (2009a). The
antibacterial activity was measured by arbitrary determina-
tion of units ranging from  (no activity) to 11111
(highest activity) by the diameter of clear zone formed
around the producer colonies.
Purification of bacteriocin and activity assay
The producer strain was inoculated into 1.5 L of tryptic soy
broth (BD) and grown at 30 1C with agitation (250 r.p.m.)
for 15 h. The culture supernatant was recovered by centrifu-
gation at 15 000 g for 20min at 4 1C and precipitated with
ammonium sulfate to 65% saturation. The precipitate
was collected by centrifugation at 16 000 g for 10min at
4 1C and dissolved with sterile deionized water. The concen-
trated bacteriocin solution was loaded onto octyl-sepharose
CL-4B (GE Healthcare, Piscataway, NJ) equilibrated with
1.7M ammonium sulfate. The hydrophobic column was
initially eluted with 200mL of 1.7M ammonium sulfate,
and then with a decreasing concentration gradient of
1.7M ammonium sulfate and deionized water (250mL).
After the first gradient elution, the column was eluted with
200mL of deionized water and an increasing gradient
elution (0–70%) with ethanol (250mL). The final elution
was performed with 100mL of 70% ethanol. The pooled
active fractions from the column were injected onto RP-
HPLC system (Agilent 1100 series, Agilent Technologies,
Wilmington, DE) using a C18 RP column (Discovery Bio
Wide pore C18, 4.6 150mm, Supelco, Bellefonte, PA). The
system was run with a linear gradient of HPLC-grade
deionized water and acetonitrile containing 0.05% trifluor-
oacetic acid (TFA; Fisher Scientific, Hampton, NH) as the
mobile phase. The signal intensity was monitored at 214 nm.
The active peak separated by RP-HPLC was fractionated
and lyophilized to perform chemical characterization
studies.
The antibacterial activity of the fractions were deter-
mined by the spot-on-lawn test (Lee et al., 2008b) using B.
cereus F4552 as an indicator strain. The arbitrary activity
units were calculated by the reciprocal of the highest
Table 1. Primers used in this study
Primer sets Sequence (50–30)
1 16S-FOR AGAGTTTGATCCTGGCTCAG
16S-REV AAGGAGGTGATCCAGCCGCA
2 BCFW1 GTTTCTGGTGGTTTACATGG
BCRW1 CAACGTATGATTTAATTCCACC
3 AB17R GCCGATGGGTAAAGAAGCCCTATA
AB6F CTCTTTCTGATAAAGTTATGGACATAATAATA
4 AB7R TTCACCATATGTTTTAACATCCTC
AB13R TATTATTATGTCCATAACTTTATCAGAAAGAG
5 AB12F GTATCCAAAGTTTACAATATGAACATTG
AB19R AATTGAGATGAAACAAGGCATCCA
6 AB18F GATACACATGCATTGGTAAAGGGC
AB20R ACCAACAGTTACATTTTTAGTTCCTGG
7 AB19F TGGATGCCTTGTTTCATCTCAATT
AB21R CCACTGTTCTAAACCATATTGCTG
8 AB20F CCAGGAACTAAAAATGTAACTGTTGGT
AB22R GGAACATAGGGAATAACAATCTTCCA
9 AB1F GATTGGACTTGTTGGAGTTGCTTA
AB4R TTAGCTTGCAGTACTAGCCCCTGT
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dilution showing inhibition per milliliter of the fractions
tested.
Determination of N-terminal sequence and
NanoESI-qTOF MS
The purified active bacteriocin from RP-HPLC was sub-
jected to N-terminal sequencing by Edman degradation,
performed by the Synthesis and Sequencing Facility at Johns
Hopkins University School of Medicine (Baltimore, MD).
Electrospray ionization (ESI)-MS was performed to de-
termine the accurate molecular mass of the HPLC-purified
bacteriocin at the Proteomics and Mass Spectrometry Facil-
ity, Donald Danforth Plant Science Center (St. Louis, MO).
The bacteriocin was analyzed on an Applied Biosystems
QSTAR XL hybrid quadrupole time-of-flight (TOF) MS
system equipped with a nanoelectrospray source.
Table 2. Antibacterial spectrum of Bacillus thuringiensis SF361
Indicator strains
Incubation
Producer strain
Media Temperature ( 1C) Bacillus thuringiensis SF361
Bacillus subtilis ATCC 6633 TSB 37 11
Bacillus subtilis ATCC 6537 TSB 37 1
Bacillus subtilis CU1065(WT) TSB 37 111
Bacillus subtilis LRB90 TSB 37 1
Bacillus subtilis LRB91 TSB 37 1
Bacillus cereus F4552 TSB 37 11111
Bacillus cereus ATCC 11778 TSB 37 
Bacillus cereus F4810 TSB 37 11111
Bacillus cereus Northland TSB 37 11111
Bacillus cereus Northview P2E018 TSB 37 11111
Geobacillus stearothermophilus ATCC 12980 TSB 50 11111
Bacillus thuringiensis EG10368 TSB 37 11111
Bacillus megaterium LRB89 TSB 37 11111
Listeria monocytogenes F2 586 1053 TSB 37 1111
Listeria monocytogenes 2289 TSB 37 1111
Listeria innocua ATCC 2283 TSB 37 11111
Listeria ivanovii ATCC 19119 TSB 37 11111
Micrococcus luteus TSB 37 1
Paenibacillus kobensis M TSB 37 
Staphylococcus aureus ATCC 9144 TSB 37 1
Staphylococcus aureus ATCC 8095 TSB 37 1
Staphylococcus aureus ATCC 25923 TSB 37 
Lactobacillus acidophilus L-39 APT 30 
Lactobacillus plantarum B246 APT 30 
Lactobacillus plantarum EH22G APT 30
Lactobacillus helveticus L-31 APT 30 
Lactobacillus delbrueckii 4797 APT 30 
Lactobacillus buchneri ATCC 4005 APT 30 
Lactobacillus fermentum ATCC14931 APT 30 
Lactobacillus casei 30SC APT 30 
Lactobacillus brevis B155 APT 30 
Leuconostoc mesenteroides C-33 APT 30 
Leuconostoc mesenteroides 548D APT 30 
Enterococcus faecalis 8043 APT 30 
Carnobacterium piscicola CU216 APT 30 11111
Pediococcus cerevisiae E66 APT 30 
Escherichia coli BF2 TSB 37 
Escherichia coli O157:H7 ATCC 43889 TSB 37 
Salmonella Typhimurium ATCC 14028 TSB 37 
Salmonella Typhimurium Montevideo TSB 37 
Salmonella Enteritidis TSB 37 
Antibacterial activity of the producer strain was graded by  (no activity) to 1111 (highest activity).
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DNA manipulation and sequence analysis
Basic DNA manipulation techniques were performed as
described by Sambrook & Russell (2001). From the results of
NCBI BLAST homology search (BLASTP) with the N-terminal
sequence, two hypothetical proteins identified by the un-
finished whole-genome shotgun sequencing of B. cereus
AH1134 (GenBank accession no.: NZ_ABDA02000035)
and their genetic flanking regions were selected to design
six sets of primers (sets 3–8) to clone the bacteriocin
biosynthesis genes of B. thuringiensis SF361 (Table 1). PCR
was performed with a program of the following conditions:
initial one cycle of 94 1C for 3min, followed by 30 cycles of a
set of reactions composed of 30 s at 94 1C, 30 s at 60 1C, and
2min at 72 1C, and one last cycle of 72 1C for 8min. The
PCR products were eluted and sequenced as described in a
previous section. Genomic analyses were performed with
LASERGENE software (Dnastar Inc., Madison, WI) and the
NCBI BLAST homology search (BLASTP).
RNA manipulation and Northern hybridization
Total RNA was extracted from exponentially growing B.
thuringiensis SF361 in Luria–Bertani medium (BD) after 5 h
of incubation (30 1C, 250 r.p.m.) with RNeasy Protect Bac-
teria Mini Kit (Qiagen). Ten micrograms of total RNA and
5mg of RNA marker (0.1–1.0 kb; Sigma, St. Louis, MO) as a
size reference were run in formaldehyde agarose gel [1.5%
(w/v)] and transferred to Hybond-N1 positively charged
nylon transfer membrane (GE Healthcare) as described by
Sambrook & Russell (2001). Northern hybridization was
performed with Amersham Gene Image AlkPhos Direct
Labelling and Detection System (GE Healthcare). The
partial structural gene of thurincin H was amplified with
the chromosomal DNA as a template using a set of primers
(set 9; Table 1) designed based on the sequence of a
structural gene, thnA2, and its termination codon (TAA).
The PCR product with a size of 96 bp was labeled by the
labeling system, and then used as a probe. After signal
generation, the signal on the membrane was exposed and
developed on a Kodak BioMax Light Film (Kodak, Roche-
ster, NY).
Nucleotide sequence accession number
The annotated DNA sequences in this paper were deposited
to GenBank, whose accession numbers are FJ160904 and
FJ977580.
Results
Identification of the bacteriocin producer
The producer was a Gram-positive, spore-forming bacter-
ium that was identified as B. thuringiensis by 16S rRNA gene
sequencing. To complement 16S rRNA gene sequencing, the
partial sequence of gyrB gene encoding subunit B protein of
DNA gyrase (topoisomerase type II) was amplified by PCR
using a specific-primer set. The sequence of gyrB of the
producer showed the highest identity (99%) to gyrB se-
quences of several B. thuringiensis strains. Based on these
results, the producer was designated as B. thuringiensis
SF361.
Antibacterial spectrum of the bacteriocin
producer
The inhibitory spectrum of B. thuringiensis SF361 was
determined against a broad range of Gram-positive and -
negative bacteria. All of Bacillus spp. except B. cereus ATCC
11778 were sensitive to the antagonistic activity of the
producer (Table 2). The producer also exhibited a high level
of antibacterial activity against Listeria spp. Among the
lactic acid bacteria, the growth of only one bacterium
(Carnobacterium piscicola CU216) was inhibited by the
antibacterial activity. Bacillus thuringiensis SF361 did not
exhibit antimicrobial activity against any of the Gram-
negative bacteria tested.
Purification, N-terminal sequencing, and MS of
thurincin H
Ammonium sulfate precipitation of the culture supernatant
resulted in the highest yield (65%) in terms of the anti-
bacterial activity. The active compound was eluted with
deionized water from octyl-sepharose CL-4B (Fig. 1a). All of
the active fractions were pooled for further purification by
RP-HPLC. The HPLC chromatogram showed that one main
peak containing the antibacterial activity was eluted with
65% acetonitrile containing 0.05% TFA (Fig. 1b). The
purified bacteriocin was designated as thurincin H.
N-terminal sequencing identified 14 amino acid residues
with four unidentified residues, DWTXWSXLVXAAXS-
VELL (X, unidentified amino acid). The molecular mass of
thurincin H was calculated to be 3139.51Da by nanoESI-
qTOF MS (Fig. 1c).
Analyses of the gene cluster of thurincin H
The PCR product from set 4 primers was sequenced to
determine the nucleotide sequence of the coding region of
thurincin H. Three ORFs (thnA1, A2, and A3) were arranged
in tandem on the sequence and all three genes encode for the
identical bacteriocin, thurincin H (Fig. 2a). Upstream of
thnA1, a putative promoter with  35 and  10 sequences
was predicted and three probable ribosome-binding sites
were located 8 bp upstream of each putative start codon
(ATG) of all three structural genes. However, no other start
codons were found upstream of the annotated start codons
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for each gene. A potential rho-independent termination site
(nucleotide 938–983) was identified downstream of thnA3.
Three ORFs of thurincin H were translated into 40-amino
acid-long prepeptide bacteriocins, METPVVQPRDWTCWS
CLVCAACSVELLNLVTAATGASTAS. They consist of an
identical nine amino acid leader peptide and an identical
mature bacteriocin comprised of 31 amino acids. The
calculated molecular mass and pI of the mature thurincin
H based on the primary structure was 3147.61Da and 3.7,
respectively. The difference of the actual and the calculated
molecular mass of thurincin H was 8.1Da.
Six PCR products obtained by primer sets 3–8 yielded a
genetic organization with a size of approximately 8.7 kb. In
total, seven ORFs flanking three thurincin H structural
genes were annotated (Fig. 2b). ThnP [465 amino acids
(aa)] and ThnB (459 aa) showed homology to the epidermin
leader peptide-processing serine protease EpiP and AlbA of
B. subtilis ssp. subtilis strain 168, an Fe–S oxidoreductase,
radical SAM superfamily, respectively. thnR encodes for a
putative transcriptional regulator, GntR family (127 aa) and
two ABC transporters, ThnD (288 aa), an ATP-binding
protein and ThnE (215 aa), a permease protein, are encoded
by two ORFs downstream of thnR. ThnT (569 aa) is
predicted to be an ABC-secretion protein. However, thnI,
encoding a hypothetical protein composed of 95 amino
acids, showed no similarity to any known bacteriocin
production genes.
Transcriptional analysis of thurincin H genes
Total RNA of B. thuringiensis SF361 was analyzed by North-
ern hybridization to determine whether the thurincin H
genes were transcribed independently or as a single tran-
scriptional unit. Using a PCR fragment with a partial
sequence of all three structural genes, a single transcript of
thurincin H genes with an approximate size of 700 nucleo-
tides was identified (Fig. 3).
Discussion
We attempted to clone the structural and accessory genes of
thurincin H produced by B. thuringiensis SF361, a bacterial
isolate from US domestic honey. By comparison of the 18
amino acids at the N-terminus of thurincin H with all
known antimicrobial peptide sequences using BLASTP,
it was revealed that two identical proteins of B. cereus
AH1134 with unknown functions showed 77.8% identities
to thurincin H. Both of the hypothetical proteins (locus tag:
BCAH1134_C0273 and C0274) were annotated by the
unfinished shotgun genome sequencing of B. cereus
AH1134. The two proteins were composed of 40 amino
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Fig. 1. (a) Chromatogram of bacteriocin produced by Bacillus thuringiensis SF361 on octyl-sepharose CL-4B. AS, ammonium sulfate.
(b) Chromatogram of octyl-sepharose CL-4B active fractions on RP-HPLC with a C18 column. (c) NanoESI-qTOF mass spectrum of HPLC-purified
thurincin H.
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acids and were identical to each other in their primary
structure and were subsequently found to be identical to the
deduced amino acid sequence of thurincin H by PCR.
However, one additional ORF encoding the same protein
by the annotation of the genome sequence of B. cereus
AH1134 was identified. It was assumed that this ORF may
have been overlooked during annotation.
Five sets of primers (sets 3, 5, 6, 7 and 8), designed based
on the up- and downstream regions of the ORFs encoding
the two proteins of B. cereus AH1134 were used for
amplification of the flanking regions of thurincin H genes.
The additional PCR showed that the annotated seven ORFs
(locus tag: BCAH1134_C0269, C0270, C0271, C0272,
C0275, C0276 and C0277) flanking two genes (locus tag:
BCAH1134_C0273 and C0274) of B. cereus AH1134 were
identical to the flanking genes, thnP, E, D, R, B, T, and I of
thurincin H structural genes with the same transcriptional
directions (Fig. 2b). ThnP and B are suggested to be related
to the processing of thuricin H, resulting in the mature
bacteriocin. Thn D and E are postulated to be associated
with bacteriocin resistance, as determined by BLASP. ThnT is
predicted to be involved as a transporter for bacteriocin
production. Interestingly, a transcription regulator, ThnR,
which may be related to two-component regulatory systems
for bacteriocin synthesis was found without the typical
paired histidine kinase in the genetic organization. It is
assumed that ThnI may be an immunity protein of thur-
incin H in terms of its short length (95 aa) compared with
subtilosin A immunity protein (AlbB; 53 aa) (Zheng et al.,
2000) even though there was no functional or homologous
evidence. Functional analyses will be conducted for the
accurate annotation of each ORF.
The reported N-terminal sequences of four similar bac-
teriocins to thurincin H from three B. thuringiensis and one
B. cereus strains showed high identities to the N-terminal
sequence of thurincin H: thuricin S (DWTXWSXL), thur-
icin 17 (DWTCWSCLVVAACSVELL), bacthuricin F4
(DWTXWSXL) and cerein MRX1 (DWTCWSCLVCAACS-
VELL) (Kamoun et al., 2005; Gray et al., 2006a, b; Chehimi
et al., 2007; Sebei et al., 2007). The determined molecular
masses of thuricin S (3137.61Da), thuricin 17 (3162Da),
bacthuricin F4 (3160.05Da), and cereinMRX1 (3137.93Da)
were slightly different from thurincin H (3139.51Da).
Recently, a bacthuricin F4 production-associated gene was
identified to be plasmid encoded (Kamoun et al., 2009). To
determine the thurincin H operon location, Southern hy-
bridization was performed using a PCR product of the
genetic locus, which included the three structural genes of
thurincin H as a probe to determine the bacteriocin operon
location. As confirmation for the chromosomal location,
(a)
(b)
Fig. 2. (a) Nucleotide sequence and deduced amino acid sequence encoding thurincin H (thnA1, thnA2, and thnA3). Start codons (atg) of three genes
are specified in bold. Putative ribosomal binding sites (rbs) and  35 and 10 sequences of predicted promoter are underlined. Upward arrows indicate
the peptide cleavage processing sites, resulting in mature thurincin H; the corresponding encoded amino acids are in bold. Two facing dotted arrows
and the shaded nucleotides represent a putative transcriptional termination site with a stem–loop structure. (b) Genetic organization of thurincin H
structural genes (black arrows) with the anking genes for the bacteriocin production (gray arrows). Bent arrow and lollipop represent the promoter and
transcription termination site of the thurincin H structural genes, respectively.
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PCR-amplified 16S rRNA gene was used as a probe. South-
ern hybridization with chromosomal and plasmid DNA of
B. thuringiensis SF361 revealed the bacteriocin gene to be
chromosomally encoded (data not shown), which is differ-
ent compared with the bacthuricin F4. This suggests that the
producer strain of thurincin H is different from that of
bacthuricin F4, located on a plasmid DNA (Kamoun et al.,
2009). As a further confirmation of the hybridization results,
it was elucidated that the phage minor structural protein
gene (GenBank accession no.: FJ499396) reported by Ka-
moun et al. (2009) was not amplified by PCR with the
chromosomal or plasmid DNA from B. thuringiensis SF361.
It was revealed that three thuricin 17 bacteriocin genes
had identical genetic structures to three thurincin H genes
(Lee et al., 2009b). However, it was elucidated that there is
one additional amino acid, methionine, in leader peptide of
thurincin H (METPVVQPR), compared with the leader
peptide of thuricin 17 (ETPVVQPR). A homologous gene
located downstream of thuricin 17 (albA) was also identified
downstream of the thurincin H structural genes (thnB) with
the same transcriptional orientation (Fig. 2b). However, two
genes (secE and nusG encoding preprotein translocase SecE
subunit and transcriptional antitermination factor, respec-
tively) upstream of the thuricin 17 genes (Lee et al., 2009b)
were not matched to the two consecutive genes upstream of
the thurincin H genes. On the contrary, thnR encoding a
transcription regulator flanked by a gene encoding for the
ATPase component of the ABC-type multidrug transport
system (ThnD) was annotated upstream of the thurincin H
genes (Fig. 2b). Both genes were elucidated to be encoded on
the noncoding strand of the thurincin H genes. It is
interesting that the identical bacteriocin structural genes
were located downstream of two totally different genes with
the opposite transcriptional direction from the same species
of bacilli. It can be assumed that this may occur during
horizontal gene transfer or by certain types of recombina-
tion events.
The thurincin H leader peptide is significantly shorter
(9 aa residues) than typical bacteriocin leader peptides
except those of three circular bacteriocins, MFL (circularin
A), MDILLE (uberolysin), and MKKAVIVE (subtilosin A)
(Zheng et al., 1999; Kemperman et al., 2003; Wirawan et al.,
2007), resulting in a prepeptide that barely spans the
cytoplasmic membrane for export. A unique type of export
and processing system might be expected for thurincin H
and the three circular bacteriocins based on the leader
peptide sequence lengths.
It was found that only eight out of 120 nucleotides are
different for all three thurincin H genes (Fig. 2a). Two
intergenic sequences (intergenic 1: 109 nt between thnA1
and thnA2; intergenic 2: 108 nt between thnA2 and thnA3)
showed very high similarity (93% identity), indicating that
the thnA genes may be the result of tandem duplication
mutations of a single gene. However, neither of the inter-
genic sequences showed any significant similarity to the
noncoding region downstream of thnA3 (167 nucleotides).
Moreover, the two intergenic regions did not contain a
notable transcriptional terminator with a stem–loop struc-
ture, suggesting that the three genes might be controlled
under the same promoter upstream of thnA1. From the
Northern hybridization, only one signal representing mRNA
with an approximate size of 700 nt was detected (Fig. 3). The
size was similar to that of the predicted mRNA size
(700 nt; Fig. 2a, nucleotides 281–291 to 983) of all three
genes transcribed under the identical putative promoter
upstream of thnA1. Therefore, the analysis confirmed that
no putative promoter regions are predicted within both
intergenic sequences and elucidated that the transcription of
all three genes is controlled by a single promoter. To our
knowledge, this is the first report showing multiple copies of
identical bacteriocin structural genes in tandem that are
regulated by the same promoter.
The genetic redundancy of multiple copies of genes has
been discovered to express elevated level of resistance to
antibiotics. Multiple tandem structural genes encoding the
same bacteriocin under the control of the same promoter
Fig. 3. Northern hybridization of total RNA extracted from Bacillus
thuringiensis SF361. Transcript of thurincin H genes with an approximate
size of 700 nt is indicated with an arrow. Lane 1, RNA marker
(0.1–1.0 kb); lane 2, total RNA of B. thuringiensis SF361 (10 mg); lane 3,
a signal representing the thurincin H transcript detected using chemilu-
minescence detection.
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may be associated with the survival of the producer strain in
a niche environment where a variety of microorganisms
compete for the limited nutrients. Production of three times
the amount of bacteriocin under the same control at the
transcriptional level during a given time would allow for
rapid increases in bacteriocin levels, thus making it possible
to compete more efficiently against other bacteria.
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